<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Inhibition of soluble <z:chebi fb="0" ids="32955">epoxide</z:chebi> hydrolase (SEH), the enzyme responsible for degradation of vasoactive <z:chebi fb="1" ids="32955">epoxides</z:chebi>, protects against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>However, the molecular and biological mechanisms that confer protection in normotension and <z:hpo ids='HP_0000822'>hypertension</z:hpo> remain unclear </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show that 6 weeks of SEH inhibition via 2 mg/day of 12-(3-<z:chebi fb="0" ids="40519">adamantan</z:chebi>-1-yl-ureido) <z:chebi fb="0" ids="30805">dodecanoic acid</z:chebi> (AUDA) in spontaneously hypertensive <z:hpo ids='HP_0001297'>stroke</z:hpo>-prone (SHRSP) rats protects against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, reducing percent hemispheric <z:mpath ids='MPATH_124'>infarct</z:mpath> and neurodeficit score without decreasing blood pressure </plain></SENT>
<SENT sid="3" pm="."><plain>This level of cerebral protection was similar to that of the <z:chebi fb="0" ids="35457">angiotensin-converting enzyme inhibitor</z:chebi>, enalapril, which significantly lowered blood pressure </plain></SENT>
<SENT sid="4" pm="."><plain>SEH inhibition is also protective in normotensive Wistar-Kyoto (WKY) rats, reducing both hemispheric <z:mpath ids='MPATH_124'>infarct</z:mpath> and neurodeficit score </plain></SENT>
<SENT sid="5" pm="."><plain>In SHRSP rats, SEH inhibition reduced wall-to-lumen ratio and collagen deposition and increased cerebral microvessel density, although AUDA did not alter middle cerebral artery structure or microvessel density in WKY rats </plain></SENT>
<SENT sid="6" pm="."><plain>An <z:mpath ids='MPATH_3'>apoptosis</z:mpath> <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression microarray of brain tissues from AUDA-treated rats revealed that AUDA modulates gene expression of mediators involved in the regulation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in neural tissues of both WKY and SHRSP rats </plain></SENT>
<SENT sid="7" pm="."><plain>Hence, we conclude that <z:hpo ids='HP_0011010'>chronic</z:hpo> SEH inhibition protects against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> via vascular protection in SHRSP rats and neural protection in both the SHRSP and WKY rats, indicating that SEH inhibition has broad pharmacological potential for treating <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>